Barclays & Mizuho Financial Group

Barclays: Barclays Capital Inc. is acting as a joint book-running manager for the public offering by Enliven Therapeutics, supporting the sale of securities.

Mizuho Financial Group: Mizuho is acting as a book-running manager for the public offering by Enliven Therapeutics.

Barclays: Barclays is identified as the UK's top financier of fossil fuels in 2025, committing USD34 billion, ranking 8th globally. While its financing decreased by 5% last year, it remains a significant contributor to fossil fuel expansion, facing scrutiny from environmental groups.

Mizuho Financial Group: Mizuho Financial Group is a Japanese bank listed among the top fossil fuel financiers, contributing to the global surge in investment.

Barclays: Barclays, an IPO bookrunner for Cerebras Systems, initiated coverage with an 'Overweight' rating and a $280 target, supporting the positive market outlook for Cerebras Systems.

Mizuho Financial Group: Mizuho Financial Group initiated coverage with an 'Outperform' rating and a $300 price target for Cerebras Systems, contributing to the positive analyst sentiment.

Barclays: Barclays is a joint book-running manager, earning fees from the offering.

Mizuho Financial Group: Mizuho is an additional bookrunner, participating in the offering.

Barclays: Barclays>>> is among the major international banks urged to focus on lining up wealthy individual buyers for the SpaceX>>> IPO.

Mizuho Financial Group: Mizuho Financial Group>>> is one of the international banks urged to line up wealthy individual buyers for the SpaceX>>> IPO in their home countries.

Barclays: Barclays provided data on oil flows through the strait.

Mizuho Financial Group: Mizuho shares edged up, but not central.

Barclays: Barclays is one of the 16 banks participating in smaller roles for the SpaceX IPO.